LETTER TO THE EDITOR
Eculizumab use throughout pregnancy in two patients with aquaporin-4-positive neuromyelitis optica spectrum disorder
Takeshi Fujimoto,
Corresponding Author
Takeshi Fujimoto
Sasebo City General Hospital, Sasebo, Japan
Correspondence
Takeshi Fujimoto, Sasebo City General Hospital, 9-3, Hirase-cho, Sasebo-city, Nagasaki-prefecture, 857-8511, Japan.
Email: [email protected]
Search for more papers by this author Yasuhiro Maeda,
Yasuhiro Maeda
Sasebo City General Hospital, Sasebo, Japan
Search for more papers by this author
Takeshi Fujimoto,
Corresponding Author
Takeshi Fujimoto
Sasebo City General Hospital, Sasebo, Japan
Correspondence
Takeshi Fujimoto, Sasebo City General Hospital, 9-3, Hirase-cho, Sasebo-city, Nagasaki-prefecture, 857-8511, Japan.
Email: [email protected]
Search for more papers by this author Yasuhiro Maeda,
Yasuhiro Maeda
Sasebo City General Hospital, Sasebo, Japan
Search for more papers by this author
First published: 30 July 2024
No abstract is available for this article.
REFERENCES
- 1Alla W, Ilya K. Response to: Eculizumab use throughout pregnancy in two patients with aquaporin-4-positive neuromyelitis optica spectrum disorder. Clin Exp Neuroimmunol. 2025; 16(1): 4–5. https://doi.org/10.1111/cen3.12807
- 2Fujimoto T, Maeda Y. Eculizumab use throughout pregnancy in two patients with aquaporin-4-positive neuromyelitis optica spectrum disorder. Clin Exp Neuroimmunol. 2024; 15(3): 126–129. https://doi.org/10.1111/cen3.12784
- 3Mao-Draayer Y, Thiel S, Mills EA, Chitnis T, Fabian M, Katz Sand I, et al. Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations. Nat Rev Neurol. 2020; 16(3): 154–170.
- 4Vu T, Harvey B, Suresh N, Farias J, Gooch C. Eculizumab during pregnancy in a patient with treatment-refractory myasthenia gravis: a case report. Case Rep Neurol. 2021; 13(1): 65–72.
- 5Bateman S, Ladhani M, Jesudason S. Successful subsequent pregnancy in a woman receiving eculizumab for pregnancy-associated atypical hemolytic uremic syndrome. Case Rep Nephrol. 2019; 2019:2738723.
